New research offers hope for patients with multiple sclerosis, after finding that a common over-the-counter antioxidant may help to slow the condition. In a pilot study, researchers found that taking a high dose of lipoic acid every day for 2 years reduced whole brain atrophy among patients with secondary progressive multiple sclerosis(SPMS), compared with a placebo. Lead...
Tag: <span>Multiple sclerosis(MS)</span>
Post
Researchers uncover potential risks of common MS treatment
In one of the most comprehensive studies to date, UBC researchers have identified potential adverse reactions of a commonly used multiple sclerosis drug. The study aimed to identify potential adverse events related to beta-interferon treatment for relapsing-remitting multiple sclerosis by analyzing health records of over 2,000 British Columbians with multiple sclerosis between 1995 and 2008. “Once a...
Post
Researchers uncover potential risks of common MS treatment
In one of the most comprehensive studies to date, UBC researchers have identified potential adverse reactions of a commonly used multiple sclerosis drug. The study aimed to identify potential adverse events related to beta-interferon treatment for relapsing-remitting multiple sclerosis by analyzing health records of over 2,000 British Columbians with multiple sclerosis between 1995 and 2008. “Once a...
- 1
- 2